# OnCo record lummicar-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/lummicar-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "lummicar-1", "NCT03975907" ;
  schema:name "LUMMICAR STUDY 1"@en ;
  schema:description "The Chinese trial behind zevor-cel's approval for multiple myeloma, showing deep and lasting responses with a fully human BCMA CAR-T."@en ;
  schema:url <https://onco.cc/trials/lummicar-1/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03975907>, <https://doi.org/10.1186/s40164-025-00710-y> ;
  onco:status "positive" ;
  onco:tag "china" ;
  onco:phase "1/2" ;
  schema:startDate "2019-06-10" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:drugs <https://onco.cc/drugs/zevorcabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/carsgen/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-chen-exp-hematol-oncol/> .